PetMed Express Inc. (NASDAQ:PETS) CEO Menderes Akdag sold 6,274 shares of the firm’s stock in a transaction that occurred on Friday, November 25th. The stock was sold at an average price of $22.25, for a total value of $139,596.50. Following the sale, the chief executive officer now directly owns 550,000 shares of the company’s stock, valued at approximately $12,237,500. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available through the SEC website.

Menderes Akdag also recently made the following trade(s):

  • On Monday, November 14th, Menderes Akdag sold 40,000 shares of PetMed Express stock. The stock was sold at an average price of $21.63, for a total value of $865,200.00.
  • On Monday, October 10th, Menderes Akdag sold 10,000 shares of PetMed Express stock. The stock was sold at an average price of $21.00, for a total value of $210,000.00.
  • On Thursday, September 22nd, Menderes Akdag sold 10,000 shares of PetMed Express stock. The stock was sold at an average price of $20.75, for a total value of $207,500.00.

PetMed Express Inc. (NASDAQ:PETS) opened at 21.83 on Thursday. The stock has a 50 day moving average price of $20.66 and a 200-day moving average price of $19.92. The company has a market cap of $442.12 million, a price-to-earnings ratio of 20.40 and a beta of 1.11. PetMed Express Inc. has a 12-month low of $15.73 and a 12-month high of $22.37.

PetMed Express (NASDAQ:PETS) last released its earnings results on Monday, October 24th. The company reported $0.24 earnings per share for the quarter, missing analysts’ consensus estimates of $0.26 by $0.02. PetMed Express had a net margin of 9.10% and a return on equity of 25.77%. The company earned $60.80 million during the quarter, compared to the consensus estimate of $58.47 million. During the same period last year, the firm posted $0.22 EPS. The company’s revenue was up 7.2% on a year-over-year basis. On average, analysts predict that PetMed Express Inc. will post $1.09 EPS for the current fiscal year.

Insider Buying and Selling by Quarter for PetMed Express (NASDAQ:PETS)

The business also recently announced a quarterly dividend, which was paid on Friday, November 18th. Stockholders of record on Monday, November 7th were paid a $0.19 dividend. This represents a $0.76 dividend on an annualized basis and a dividend yield of 3.48%. The ex-dividend date of this dividend was Thursday, November 3rd. PetMed Express’s dividend payout ratio (DPR) is presently 71.03%.

COPYRIGHT VIOLATION NOTICE: “Menderes Akdag Sells 6,274 Shares of PetMed Express Inc. (PETS) Stock” was originally published by The Cerbat Gem and is owned by of The Cerbat Gem. If you are reading this news story on another website, it was copied illegally and reposted in violation of international copyright and trademark laws. The correct version of this news story can be viewed at https://www.thecerbatgem.com/2016/12/01/menderes-akdag-sells-6274-shares-of-petmed-express-inc-pets-stock.html.

Several large investors have recently added to or reduced their stakes in PETS. NEXT Financial Group Inc increased its position in shares of PetMed Express by 167.2% in the second quarter. NEXT Financial Group Inc now owns 5,354 shares of the company’s stock worth $100,000 after buying an additional 3,350 shares in the last quarter. BNP Paribas Arbitrage SA increased its position in shares of PetMed Express by 101.2% in the second quarter. BNP Paribas Arbitrage SA now owns 6,206 shares of the company’s stock worth $116,000 after buying an additional 3,121 shares in the last quarter. Royal Bank of Canada increased its position in shares of PetMed Express by 19.6% in the second quarter. Royal Bank of Canada now owns 6,423 shares of the company’s stock worth $120,000 after buying an additional 1,053 shares in the last quarter. Cutler Group LP increased its position in shares of PetMed Express by 832.0% in the second quarter. Cutler Group LP now owns 7,064 shares of the company’s stock worth $132,000 after buying an additional 8,029 shares in the last quarter. Finally, Bank of Montreal Can acquired a new position in shares of PetMed Express during the second quarter worth about $143,000. 73.97% of the stock is owned by institutional investors.

Several brokerages have issued reports on PETS. Zacks Investment Research lowered PetMed Express from a “hold” rating to a “sell” rating in a report on Thursday, October 27th. Credit Suisse Group AG reiterated a “sell” rating and issued a $13.00 price target on shares of PetMed Express in a report on Tuesday, August 16th.

About PetMed Express

PetMed Express, Inc (PetMed Express), doing business as 1800PetMeds, is a pet pharmacy. The Company markets prescription and non-prescription pet medications, and other health products for dogs and cats, direct to the consumer. It offers a selection of products for dogs and cats. Its product line contains approximately 3,000 stock keeping units (SKUS) of pet medications, health products and supplies.

5 Day Chart for NASDAQ:PETS

Receive News & Stock Ratings for PetMed Express Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for PetMed Express Inc. and related stocks with our FREE daily email newsletter.